Elisa Gelli

Two‐point‐NGS analysis of cancer genes in cell‐free DNA of metastatic cancer patients

D. Galimberti, A. Pinto, F. Fava, 2020, Cancer medicine.

Usefulness and Limitations of Comprehensive Characterization of mRNA Splicing Profiles in the Definition of the Clinical Relevance of BRCA1/2 Variants of Uncertain Significance

P. Radice, S. Manoukian, E. Trevisson, 2019, Cancers.

Evidence of predisposing epimutation in retinoblastoma

T. Hadjistilianou, D. Galimberti, A. Pinto, 2018, Human mutation.

CD38-Induced Metabolic Dysfunction Primes Multiple Myeloma Cells for NAD+-Lowering Agents

A. Neri, A. De Flora, S. Bruzzone, 2023, Antioxidants.

RB1 Germline Variant Predisposing to a Rare Ovarian Germ Cell Tumor: A Case Report

C. Fallerini, A. Renieri, M. Mencarelli, 2020, Frontiers in Oncology.

Parent-of-origin effect of hypomorphic pathogenic variants and somatic mosaicism impact on phenotypic expression of retinoblastoma

T. Hadjistilianou, V. Capra, E. Trevisson, 2018, European Journal of Human Genetics.

Targeting the deacetylase SIRT6 unveils spliceosome deregulation as exploitable vulnerability for aggressive myeloma

A. Neri, S. Bruzzone, A. Nencioni, 2023, Blood Advances.

Apoptosis reprogramming triggered by splicing inhibitors sensitizes multiple myeloma cells to Venetoclax treatment

N. Munshi, M. Samur, A. Neri, 2021, Haematologica.